Just Other Articles

Great isn’t it! Competition is everywhere. Tennis, soccer, football, the Olympic Games. It

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

is the gold medal that counts.

In search-engine country the competition is also fierce.

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

Who will win? Will there be only winners and losers? And can you compare the companies men

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

tioned in the title? Are they focused enough to compete? Are they running at the same trac

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

k?

Companies compete on different elements. Airbus is taking space or volume as a target,

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

Boeing’s answer to the challenge is velocity: “we can go faster”.

And – this is where th

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

e article is about – what is your internal organization doing in this area? Do people and

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

epartments compete up to any level? And how is it with the cooperation between the various

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

teams. Does your company value the individual hero with “the employee of the month” or do

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

they choose for a less visible team approach giving away a team bonus.

There are many wa

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ys you can organize activities. We are all familiar with competition, yet there is one pro

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

blem with it (a small side effect to all the good things it also brings).

Imagine that yo

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ur company is opening up for others. Do not ask me why they all of a sudden want this, but

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

it is like a trend. You should connect. And then you are talking about this system, this

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ethod, our approach and theirs. There is no fit. And we all know where the problem is: At

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

the interface level. It is their protocol against ours. We communicate, but the message do

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

esn’t get acknowledged.

So what to do? Stay small and beautiful? But small is not an opti

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

on in competition. It is bigger, faster, easier - everything but smaller.

So how to solve

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

the side effects?

Please continue reading this some other moment in time and find out ho

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/4152/justotherarticles-Competition--Side-Effects-Live-Reported-From-the-Stock-Exchange-GOOG-41559--YHOO-4091.html">Competition & Side Effects: Live Reported From the Stock Exchange: GOOG ($415,59) - YHOO ($40,91)</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/4152/justotherarticles-Competition--Side-Effects-Live-Reported-From-the-Stock-Exchange-GOOG-41559--YHOO-4091.html]Competition & Side Effects: Live Reported From the Stock Exchange: GOOG ($415,59) - YHOO ($40,91)[/url]

Senior citizens often use up their retirement money on medical billing as they do not have other sources of income. One way to cover medical billing for senior citizens is to obtain insurance coverage for hospitalization and surgery costs.

Hate bookkeeping? You're not alone! However, as bad bookkeeping (or a bad bookkeeper) can help make or break your business, be sure to read the these 7 tips before you hire a bookkeeper. Doing it right the first time will save you time, frustration and money later on!

We now live in a world where just about individual wants everything that they use or do to be as easy as it could possibly be. That is one of the reasons why digital mass flow controllers are popular mass flow control products that are used in a wide variety of industries. Although digital mass control products are often considered the most popular they are not the only products currently available on the market.

Tags

Links

Just Other Articles - Competition & Side Effects: Live Reported From the Stock Exchange: GOOG ($415,59) - YHOO ($40,91)

Related Articles: